Rights and permissions
About this article
Cite this article
Cisplatin + doxorubicin is effective against childhood hepatoblastoma and hepatocellular carcinoma. Inpharma Wkly. 791, 16 (1991). https://doi.org/10.2165/00128413-199107910-00046
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199107910-00046